212 related articles for article (PubMed ID: 16516369)
1. Bromate: concern for developmental neurotoxicity?
Crofton KM
Toxicology; 2006 Apr; 221(2-3):212-6. PubMed ID: 16516369
[TBL] [Abstract][Full Text] [Related]
2. Research strategy for developing key information on bromate's mode of action.
Bull RJ; Cottruvo JA
Toxicology; 2006 Apr; 221(2-3):135-44. PubMed ID: 16298034
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of developmental neurotoxicity of organotins via drinking water in rats: dimethyl tin.
Ehman KD; Phillips PM; McDaniel KL; Barone S; Moser VC
Neurotoxicol Teratol; 2007; 29(6):622-33. PubMed ID: 17764894
[TBL] [Abstract][Full Text] [Related]
4. Bromate-induced ototoxicity.
Campbell KC
Toxicology; 2006 Apr; 221(2-3):205-11. PubMed ID: 16460859
[TBL] [Abstract][Full Text] [Related]
5. Approaches to determining regulatory values for carcinogens with particular reference to bromate.
Fawell J; Walker M
Toxicology; 2006 Apr; 221(2-3):149-53. PubMed ID: 16466841
[TBL] [Abstract][Full Text] [Related]
6. Developmental neurotoxicity of propylthiouracil (PTU) in rats: relationship between transient hypothyroxinemia during development and long-lasting behavioural and functional changes.
Axelstad M; Hansen PR; Boberg J; Bonnichsen M; Nellemann C; Lund SP; Hougaard KS; Hass U
Toxicol Appl Pharmacol; 2008 Oct; 232(1):1-13. PubMed ID: 18573268
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of bromate: implications for cancer risk assessment.
Moore MM; Chen T
Toxicology; 2006 Apr; 221(2-3):190-6. PubMed ID: 16460860
[TBL] [Abstract][Full Text] [Related]
8. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Crofton KM; Foss JA; Hass U; Jensen KF; Levin ED; Parker SP
Neurotoxicol Teratol; 2008; 30(4):266-87. PubMed ID: 17681747
[TBL] [Abstract][Full Text] [Related]
9. Development of a rat dosimetry model for bromate.
Fisher J; Bull RJ
Toxicology; 2006 Apr; 221(2-3):235-40. PubMed ID: 16500013
[TBL] [Abstract][Full Text] [Related]
10. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
Hass U
Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
[TBL] [Abstract][Full Text] [Related]
11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of conducting human studies to address bromate risks.
Cantor KP
Toxicology; 2006 Apr; 221(2-3):197-204. PubMed ID: 16352386
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicology risk assessment guidelines: developmental neurotoxicology.
Tilson HA
Neurotoxicology; 2000; 21(1-2):189-94. PubMed ID: 10794399
[TBL] [Abstract][Full Text] [Related]
14. Analysis and integration of developmental neurotoxicity and ancillary data into risk assessment: a case study of dimethoate.
DeSesso JM; Watson RE; Keen CL; Hazelden KP; Haws LC; Li AA
J Toxicol Environ Health A; 2009; 72(2):94-109. PubMed ID: 19034799
[TBL] [Abstract][Full Text] [Related]
15. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
Wang C; Slikker W
Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
[TBL] [Abstract][Full Text] [Related]
16. Lead contamination in Uruguay: the "La Teja" neighborhood case.
Mañay N; Cousillas AZ; Alvarez C; Heller T
Rev Environ Contam Toxicol; 2008; 195():93-115. PubMed ID: 18418955
[TBL] [Abstract][Full Text] [Related]
17. In-home toxic chemical exposures and children with intellectual and developmental disabilities.
Graff JC; Murphy L; Ekvall S; Gagnon M
Pediatr Nurs; 2006; 32(6):596-603. PubMed ID: 17256300
[TBL] [Abstract][Full Text] [Related]
18. Quantitative risk assessment for developmental neurotoxic effects.
Razzaghi M; Kodell R
Risk Anal; 2004 Dec; 24(6):1673-81. PubMed ID: 15660620
[TBL] [Abstract][Full Text] [Related]
19. Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers.
Castoldi AF; Johansson C; Onishchenko N; Coccini T; Roda E; Vahter M; Ceccatelli S; Manzo L
Regul Toxicol Pharmacol; 2008 Jul; 51(2):201-14. PubMed ID: 18367301
[TBL] [Abstract][Full Text] [Related]
20. Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
Tyl RW; Crofton K; Moretto A; Moser V; Sheets LP; Sobotka TJ
Neurotoxicol Teratol; 2008; 30(4):349-81. PubMed ID: 17826946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
